QELBREE 100 mg/1 (Viloxazine Hydrochloride CAPSULE, EXTENDED RELEASE) 100 mg/1

QELBREE 100 mg/1 is an extended-release capsule containing viloxazine hydrochloride. It is used to manage certain mental health conditions. Learn more about its uses and effects.

Strength

100 mg/1

Pack Size

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-01)

Manufacturer / TM Owner

Supernus Pharmaceuticals, Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

QELBREE 100 mg/1 is primarily used for managing attention deficit hyperactivity disorder (ADHD). Viloxazine hydrochloride, the active ingredient, is designed to provide extended-release benefits. This medication is often prescribed to help improve focus and reduce impulsivity. What is QELBREE used for? It is commonly used as part of a treatment plan for ADHD in adults and children.

Side Effects

Common effects of QELBREE 100 mg/1 may include changes in mood, appetite, and sleep patterns. Some users report feeling more focused and less impulsive. However, individual experiences can vary. It is important to monitor for any unusual side effects and consult a healthcare provider if necessary.

Precautions & Warnings

QELBREE 100 mg/1 should be stored at room temperature away from moisture and heat. Keep the medication out of reach of children. Always follow the prescribed dosage and administration instructions provided by your healthcare provider. Do not share this medication with others.

Avoid Interactions

QELBREE 100 mg/1 may interact with certain medications, including other ADHD treatments, antidepressants, and drugs that affect liver enzymes. Alcohol consumption should be avoided while taking this medication. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

QELBREE 100 mg/1 is used to manage attention deficit hyperactivity disorder (ADHD).

Store QELBREE 100 mg/1 at room temperature away from moisture and heat.

It is recommended to avoid alcohol while taking QELBREE 100 mg/1.

Common effects may include changes in mood, appetite, and sleep patterns.

QELBREE 100 mg/1 is prescribed for both adults and children with ADHD, but always consult a healthcare provider for specific advice.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.